Mereo Biopharma Group Plc ADR (NASDAQ: MREO) on Tuesday, soared 5.00% from the previous trading day, before settling in for the closing price of $2.0. Within the past 52 weeks, MREO’s price has moved between $1.47 and $4.39.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.82%. The company achieved an average annual earnings per share of 31.25%. With a float of $131.27 million, this company’s outstanding shares have now reached $159.00 million.
Mereo Biopharma Group Plc ADR (MREO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mereo Biopharma Group Plc ADR is 17.44%, while institutional ownership is 51.99%.
Mereo Biopharma Group Plc ADR (MREO) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.02 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.01) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 34.82% growth over the previous five years of trading.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Mereo Biopharma Group Plc ADR (MREO) is currently performing well based on its current performance indicators. A quick ratio of 8.13 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 654.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
Looking closely at Mereo Biopharma Group Plc ADR (NASDAQ: MREO), its last 5-days average volume was 2.05 million, which is a jump from its year-to-date volume of 1.64 million. As of the previous 9 days, the stock’s Stochastic %D was 27.56%.
During the past 100 days, Mereo Biopharma Group Plc ADR’s (MREO) raw stochastic average was set at 39.87%, which indicates a significant decrease from 47.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.12 in the past 14 days, which was higher than the 0.11 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.88, while its 200-day Moving Average is $2.28. However, in the short run, Mereo Biopharma Group Plc ADR’s stock first resistance to watch stands at $2.17. Second resistance stands at $2.23. The third major resistance level sits at $2.33. If the price goes on to break the first support level at $2.01, it is likely to go to the next support level at $1.91. Now, if the price goes above the second support level, the third support stands at $1.85.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Key Stats
Market capitalization of the company is 333.90 million based on 159,000K outstanding shares. Right now, sales total 0 K and income totals -43,250 K. The company made 500 K in profit during its latest quarter, and -14,620 K in sales during its previous quarter.
